Hmdb loader
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-13 11:51:58 UTC
Update Date2022-03-07 02:57:14 UTC
HMDB IDHMDB0041991
Secondary Accession Numbers
  • HMDB41991
Metabolite Identification
Common NamePitavastatin
DescriptionMost statins are metabolised in part by one or more hepatic cytochrome P450 enzymes, leading to an increased potential for drug interactions and problems with certain foods (such as grapefruit juice). Pitavastatin appears to be a substrate of CYP2C9, and not CYP3A4 (which is a common source of interactions in other statins). As a result, pitavastatin is less likely to interact with drugs that are metabolized via CYP3A4, which might be important for elderly patients who need to take multiple medicines. Pitavastatin (usually as a calcium salt) is a member of the medication class of statins, marketed in the United States under the trade name Livalo. Like other statins, it is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis. It has been available in Japan since 2003, and is being marketed under licence in South Korea and in India. It is likely that pitavastatin will be approved for use in hypercholesterolaemia (elevated levels of cholesterol in the blood) and for the prevention of cardiovascular disease outside South and Southeast Asia as well.
Structure
Data?1563863720
Synonyms
ValueSource
NK 104ChEBI
NK-104ChEBI
PitavastatiaChEBI
PitavastatineChEBI
PitavastatinumChEBI
Pitavastatin calciumHMDB
ItavastatinHMDB
NisvastatinHMDB
Pitavastatin lactoneHMDB
(e,3R,5S)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acidMeSH
Itavastatin calciumMeSH
Chemical FormulaC25H24FNO4
Average Molecular Weight421.4608
Monoisotopic Molecular Weight421.168936466
IUPAC Name(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid
Traditional Namepitavastatin
CAS Registry Number147511-69-1
SMILES
O[C@H](C[C@H](O)\C=C\C1=C(C2=CC=C(F)C=C2)C2=CC=CC=C2N=C1C1CC1)CC(O)=O
InChI Identifier
InChI=1S/C25H24FNO4/c26-17-9-7-15(8-10-17)24-20-3-1-2-4-22(20)27-25(16-5-6-16)21(24)12-11-18(28)13-19(29)14-23(30)31/h1-4,7-12,16,18-19,28-29H,5-6,13-14H2,(H,30,31)/b12-11+/t18-,19-/m1/s1
InChI KeyVGYFMXBACGZSIL-MCBHFWOFSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as phenylquinolines. These are heterocyclic compounds containing a quinoline moiety substituted with a phenyl group.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassQuinolines and derivatives
Sub ClassPhenylquinolines
Direct ParentPhenylquinolines
Alternative Parents
Substituents
  • Phenylquinoline
  • 4-phenylpyridine
  • Medium-chain hydroxy acid
  • Medium-chain fatty acid
  • Beta-hydroxy acid
  • Fluorobenzene
  • Halobenzene
  • Halogenated fatty acid
  • Heterocyclic fatty acid
  • Hydroxy fatty acid
  • Aryl fluoride
  • Aryl halide
  • Monocyclic benzene moiety
  • Hydroxy acid
  • Fatty acyl
  • Fatty acid
  • Pyridine
  • Unsaturated fatty acid
  • Benzenoid
  • Heteroaromatic compound
  • Secondary alcohol
  • Carboxylic acid
  • Monocarboxylic acid or derivatives
  • Azacycle
  • Carboxylic acid derivative
  • Organohalogen compound
  • Organic oxide
  • Organopnictogen compound
  • Organic oxygen compound
  • Organofluoride
  • Organonitrogen compound
  • Organooxygen compound
  • Alcohol
  • Organic nitrogen compound
  • Carbonyl group
  • Hydrocarbon derivative
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.0039 g/LALOGPS
logP3.75ALOGPS
logP2.92ChemAxon
logS-5ALOGPS
pKa (Strongest Acidic)4.13ChemAxon
pKa (Strongest Basic)4.86ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area90.65 ŲChemAxon
Rotatable Bond Count8ChemAxon
Refractivity115.74 m³·mol⁻¹ChemAxon
Polarizability43.76 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+200.08430932474
DeepCCS[M-H]-197.68830932474
DeepCCS[M-2H]-230.68630932474
DeepCCS[M+Na]+205.99730932474
AllCCS[M+H]+203.232859911
AllCCS[M+H-H2O]+200.832859911
AllCCS[M+NH4]+205.532859911
AllCCS[M+Na]+206.132859911
AllCCS[M-H]-202.532859911
AllCCS[M+Na-2H]-202.832859911
AllCCS[M+HCOO]-203.232859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.7.06 minutes32390414
Predicted by Siyang on May 30, 202211.8152 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20221.85 minutes32390414
AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid127.6 seconds40023050
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid2490.3 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid222.9 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid195.7 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid184.7 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid309.4 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid477.0 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid413.5 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)144.0 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid1003.7 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid458.2 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1312.5 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid298.0 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid341.1 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate335.4 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA169.7 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water71.4 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
PitavastatinO[C@H](C[C@H](O)\C=C\C1=C(C2=CC=C(F)C=C2)C2=CC=CC=C2N=C1C1CC1)CC(O)=O5322.9Standard polar33892256
PitavastatinO[C@H](C[C@H](O)\C=C\C1=C(C2=CC=C(F)C=C2)C2=CC=CC=C2N=C1C1CC1)CC(O)=O2987.0Standard non polar33892256
PitavastatinO[C@H](C[C@H](O)\C=C\C1=C(C2=CC=C(F)C=C2)C2=CC=CC=C2N=C1C1CC1)CC(O)=O3497.9Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Pitavastatin,1TMS,isomer #1C[Si](C)(C)O[C@@H](CC(=O)O)C[C@H](O)/C=C/C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C13606.4Semi standard non polar33892256
Pitavastatin,1TMS,isomer #2C[Si](C)(C)O[C@H](/C=C/C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C[C@@H](O)CC(=O)O3671.9Semi standard non polar33892256
Pitavastatin,1TMS,isomer #3C[Si](C)(C)OC(=O)C[C@H](O)C[C@H](O)/C=C/C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C13600.9Semi standard non polar33892256
Pitavastatin,2TMS,isomer #1C[Si](C)(C)OC(=O)C[C@@H](C[C@H](O)/C=C/C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)O[Si](C)(C)C3530.0Semi standard non polar33892256
Pitavastatin,2TMS,isomer #2C[Si](C)(C)O[C@H](/C=C/C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C[C@H](CC(=O)O)O[Si](C)(C)C3574.1Semi standard non polar33892256
Pitavastatin,2TMS,isomer #3C[Si](C)(C)OC(=O)C[C@H](O)C[C@@H](/C=C/C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)O[Si](C)(C)C3583.4Semi standard non polar33892256
Pitavastatin,3TMS,isomer #1C[Si](C)(C)OC(=O)C[C@@H](C[C@@H](/C=C/C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)O[Si](C)(C)C)O[Si](C)(C)C3534.7Semi standard non polar33892256
Pitavastatin,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)O[C@@H](CC(=O)O)C[C@H](O)/C=C/C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C13859.1Semi standard non polar33892256
Pitavastatin,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)O[C@H](/C=C/C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C[C@@H](O)CC(=O)O3904.3Semi standard non polar33892256
Pitavastatin,1TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)C[C@H](O)C[C@H](O)/C=C/C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C13852.1Semi standard non polar33892256
Pitavastatin,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)C[C@@H](C[C@H](O)/C=C/C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)O[Si](C)(C)C(C)(C)C3981.9Semi standard non polar33892256
Pitavastatin,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)O[C@H](/C=C/C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C[C@H](CC(=O)O)O[Si](C)(C)C(C)(C)C4036.0Semi standard non polar33892256
Pitavastatin,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)C[C@H](O)C[C@@H](/C=C/C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)O[Si](C)(C)C(C)(C)C4026.9Semi standard non polar33892256
Pitavastatin,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)C[C@@H](C[C@@H](/C=C/C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C4148.8Semi standard non polar33892256
Spectra
Biological Properties
Cellular Locations
  • Membrane (predicted from logP)
Biospecimen LocationsNot Available
Tissue LocationsNot Available
Pathways
Normal Concentrations
Not Available
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB08860
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID4445604
KEGG Compound IDC13334
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkPitavastatin
METLIN IDNot Available
PubChem Compound5282452
PDB IDNot Available
ChEBI ID32020
Food Biomarker OntologyNot Available
VMH IDPTVST
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General ReferencesNot Available